• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Yellow fever in Cameroon (WHO, October 8 2013)

Giuseppe

Emeritus
[Source: World Health Organization, full page: (LINK).]


Yellow fever in Cameroon

8 October 2013


The Ministry of Health of Cameroon carried out a yellow fever mass vaccination campaign with a reported 94% coverage of the targeted population of 663 900 in 13 health districts considered to be at high risk of yellow fever.

The vaccination campaign was carried out between 27 August to 1 September 2013 in the Littoral Region, following laboratory-confirmation of two cases with yellow fever in the area in April 2013. The index case was a 43-year-old woman from Ndom Health district who became ill on 15 March 2013.

The patients were laboratory confirmed at the Institute Pasteur of Cameroon by IgM ELISA (antibody) test, which was followed by the seroneutralizing test (PRNT) for yellow fever by the Institute Pasteur in Dakar, Senegal, a WHO regional reference laboratory for yellow fever.

In 2012, suspected cases were reported from the South-West area which includes North-West, South-West and West regions. These cases were identified as part of the surveillance system which identifies patients with fever and jaundice within the 14 days of onset.

WHO country office has been working with the health authorities in the field investigation and response to the outbreak. There is ongoing surveillance for yellow fever in the country.

GAVI Alliance and the International Coordinating Group on Yellow Fever Vaccine Provision (YF-ICG<SUP>1</SUP>) supported the reactive mass vaccination campaign which covered over 663 900 people in 13 health districts considered to be at high risk for yellow fever, namely Dibombari, Edea, Loum, Manjo, Manoka, Mbanga, Melong, Ndom, Ngambe, Nkondjock, Nkongsamba, Pouma and Yabass.
____
<SUP></SUP>
<SUP>1</SUP>The YF-ICG is a partnership that manages the stockpile of yellow fever vaccines for emergency response on the basis of a rotation fund. It is represented by United Nations Children's Fund (UNICEF), M?decins Sans Fronti?res (MSF) and the International Federation of Red Cross and Red Crescent Societies (IFRC) and WHO, which also serves as the Secretariat. The stockpile was created by GAVI Alliance.


-
------
 
Back
Top Bottom